- $18.42bn
- $22.56bn
- $3.52bn
- 90
- 10
- 92
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,591 | 1,859 | 2,299 | 3,282 | 3,524 |
Cost of Revenue | |||||
Gross Profit | 712 | 850 | 1,060 | 1,396 | 1,498 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,230 | 1,466 | 1,770 | 2,805 | 3,044 |
Operating Profit | 361 | 393 | 528 | 477 | 480 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 318 | 354 | 479 | 247 | 173 |
Provision for Income Taxes | |||||
Net Income After Taxes | 255 | 295 | 409 | 209 | 181 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 255 | 295 | 409 | 209 | 181 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 255 | 295 | 409 | 209 | 181 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.35 | 2.38 | 3.39 | 3 | 2.17 |
Dividends per Share |